🇺🇸 FDA
Patent

US 7572771

Multi-domain amphipathic helical peptides and methods of their use

granted A61KA61K38/00A61P

Quick answer

US patent 7572771 (Multi-domain amphipathic helical peptides and methods of their use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/00, A61P, A61P29/00, A61P3/00